Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 1,871.50p on 02-09-2026 at 05:00:08
Change 0.00p 0%
Buy 1,956.00p
Sell 1,825.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Sell 7,999.00 at 1,871.50p
Day's Volume: 0
Last Close: 1,871.50p
Open: 0.00p
ISIN: GB00BN7SWP63
Day's Range 0.00p - 0.00p
52wk Range: 1,445.50p - 2,282.00p
Market Capitalisation: £74.99b
VWAP: 0.00p
Shares in Issue: 4.01b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Higher Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 7,999 1,871.50p SI Trade
Suspected SELL Trade
 17:38:05 - 01-Sep-26
Sell* 6,352 1,871.50p SI Trade
Suspected SELL Trade
 17:38:05 - 01-Sep-26
Sell* 924 1,871.50p SI Trade
Suspected SELL Trade
 17:37:45 - 01-Sep-26
Sell* 1,118 1,871.50p SI Trade
Suspected SELL Trade
 17:37:45 - 01-Sep-26
Sell* 1,163 1,871.50p SI Trade
Suspected SELL Trade
 17:37:45 - 01-Sep-26
Sell* 2,091 1,871.50p SI Trade
Suspected SELL Trade
 17:37:45 - 01-Sep-26
Sell* 46,699 1,871.50p SI Trade
Suspected SELL Trade
 17:37:45 - 01-Sep-26
Sell* 883 1,871.50p SI Trade
Suspected SELL Trade
 17:37:45 - 01-Sep-26
Sell* 24,482 1,871.50p SI Trade
Suspected SELL Trade
 17:28:22 - 01-Sep-26
Sell* 37 1,871.50p SI Trade
Suspected SELL Trade
 16:54:11 - 01-Sep-26
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
1st Sep 2026 (Tue) 1,847.50 1,892.00 1,842.00 1,871.50 4,718,988
31st Aug 2026 (Mon) 1,853.50 1,853.50 1,853.50 1,853.50 0
28th Aug 2026 (Fri) 1,862.50 1,863.00 1,839.50 1,853.50 7,789,320
27th Aug 2026 (Thu) 1,890.00 1,902.00 1,852.00 1,852.00 3,594,159
26th Aug 2026 (Wed) 1,914.00 1,919.00 1,891.00 1,899.50 3,465,884
25th Aug 2026 (Tue) 1,900.50 1,912.00 1,868.50 1,905.50 4,599,109
24th Aug 2026 (Mon) 1,917.00 1,921.50 1,882.00 1,890.50 5,274,882
21st Aug 2026 (Fri) 1,899.00 1,919.00 1,875.50 1,918.50 4,819,444
20th Aug 2026 (Thu) 1,927.00 1,936.50 1,902.00 1,920.50 8,380,816
19th Aug 2026 (Wed) 1,890.00 1,932.50 1,873.00 1,916.00 4,489,776
18th Aug 2026 (Tue) 1,861.50 1,893.00 1,851.50 1,888.00 3,706,336
17th Aug 2026 (Mon) 1,829.00 1,859.00 1,829.00 1,851.50 3,968,556
14th Aug 2026 (Fri) 1,855.50 1,856.00 1,803.50 1,817.50 14,890,876
13th Aug 2026 (Thu) 1,848.00 1,861.00 1,841.50 1,856.50 3,942,926
12th Aug 2026 (Wed) 1,889.00 1,891.00 1,843.00 1,869.00 6,128,496
11th Aug 2026 (Tue) 1,926.00 1,948.50 1,894.00 1,896.00 4,542,799
10th Aug 2026 (Mon) 1,970.00 1,972.00 1,904.00 1,927.50 5,928,673
7th Aug 2026 (Fri) 1,931.00 1,970.50 1,931.00 1,960.50 4,447,376
6th Aug 2026 (Thu) 1,934.00 1,954.00 1,928.00 1,936.50 3,138,502
5th Aug 2026 (Wed) 1,922.00 1,964.50 1,913.00 1,915.50 8,739,080
4th Aug 2026 (Tue) 1,918.50 1,925.50 1,890.50 1,914.50 6,266,534
3rd Aug 2026 (Mon) 1,947.50 1,963.00 1,906.00 1,909.50 5,576,085
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
1st Sep 2026 3:00 pm RNS Total Voting Rights
1st Sep 2026 7:00 am RNS mRNA flu vaccine candidate to advance to phase III
26th Aug 2026 3:30 pm RNS Director/PDMR Shareholding
24th Aug 2026 3:30 pm RNS Director/PDMR Shareholding
24th Aug 2026 7:02 am RNS First global approval for Hibsago in Japan
24th Aug 2026 7:00 am RNS US FDA to review Jemperli for rectal cancer
18th Aug 2026 3:30 pm RNS Director/PDMR Shareholding
13th Aug 2026 3:33 pm RNS Director/PDMR Shareholding
11th Aug 2026 3:30 pm RNS Director/PDMR Shareholding
3rd Aug 2026 3:00 pm RNS Total Voting Rights
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

GSK advances mRNA flu vaccine to phase 3 after positive results

1st Sep 2026 11:23

(Alliance News) - GSK PLC on Tuesday said a phase 2 probe of its mRNA flu vaccine candidate showed positive results and that phase 3 trials will start this month. Read More

LONDON BRIEFING: UK house prices subdued; Bunzl lifts outlook

1st Sep 2026 07:58

(Alliance News) - UK house price growth remains subdued in August despite a modest monthly recovery. Bunzl upgrades its full-year outlook and announces a GBP500 million share buyback, while Bodycote and Gamma Communications accept takeover offers. Read More

LONDON MARKET CLOSE: FTSE down as inflation fear offsets Nvidia lift

27th Aug 2026 17:01

(Alliance News) - The FTSE 100 faltered on Thursday, despite technology focused stocks getting a boost from Nvidia, with investors wary ahead of Kevin Warsh's speech at Jackson Hole. Read More

LONDON MARKET CLOSE: FTSE 100 outperforms as oil price heads lower

24th Aug 2026 17:04

(Alliance News) - The FTSE 100 closed higher in London on Monday, outperforming European peers, as oil prices edged lower and investors looked ahead to key events in the US later this week. Read More

IN BRIEF: GSK US President sells shares worth USD2.3 million

24th Aug 2026 16:50

GSK PLC - London-based pharmaceutical firm - President of the US business Maya Martinez-Davis sells 3,916 American depository receipts at an average price of USD52.14 each, worth approximately GBP204,180 in total, on Thursday in New York. On Friday, Martinez-Davis sells 40,481 ADRs, also at an average USD52.14 each, worth about USD2.1 million. Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value10,789.28
Change-34.98

Login to your account

Forgot Password?

Not Registered